WO2006080522A1 - ミネラル含有乳酸菌を含んでなる食品または医薬品 - Google Patents
ミネラル含有乳酸菌を含んでなる食品または医薬品 Download PDFInfo
- Publication number
- WO2006080522A1 WO2006080522A1 PCT/JP2006/301539 JP2006301539W WO2006080522A1 WO 2006080522 A1 WO2006080522 A1 WO 2006080522A1 JP 2006301539 W JP2006301539 W JP 2006301539W WO 2006080522 A1 WO2006080522 A1 WO 2006080522A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lactic acid
- acid bacterium
- food
- composition according
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Definitions
- the present invention relates to a composition containing lactic acid bacteria containing a high concentration of a mineral component and dispersed and dissolved in an aqueous medium.
- Mineral is a nutrient that is essential for the regulation of human physiological functions. It is a nutrient that cannot be made by the human body, and therefore must be taken from outside. When minerals are deficient, for example, zinc causes taste disorders and decreased immune function, and copper has been observed to have heart-related abnormalities in addition to anemia. The ability to determine the appropriate amount of minerals so far The “Food intake standards for Japanese”, which will be adopted for five years from April 2005 to March 2010, Mineral intake standards are established.
- Japanese Patent Application Laid-Open No. 2001-46016 proposes a liquid food to which yeast containing a high concentration of minerals is added.
- yeast containing a high amount of minerals when yeast containing a high amount of minerals is used, if the blending amount exceeds 0.2% by weight, precipitation of the yeast occurs, dispersion stability deteriorates, and physical problems tend to occur.
- a rough feeling is seen in sensory evaluation.
- the taste and flavor of the yeast itself are likely to develop off-flavors and off-flavors due to deterioration during storage that is poor in palatability.
- W092Z21749 (corresponding Japanese Patent Publication No. Hei 6-508516) discloses a method for producing lactic acid bacteria containing a high concentration of minerals. Specific methods using the obtained lactic acid bacteria as a raw material are disclosed. There is no disclosure of food and medicine.
- lactic acid bacteria containing a high concentration of mineral components are excellent in dispersion and solubility in aqueous media such as water, and are stable after dissolution. Dispersed 'dissolved as a food or pharmaceutical product is also good in appearance, taste, flavor, and texture such as roughness, so it is advantageous for a composition that is dispersed and dissolved in an aqueous medium.
- the knowledge that it can be used was obtained.
- the present invention is based on strong knowledge.
- the present invention is a composition that is used after being dispersed * dissolved in an aqueous medium, and is excellent in dispersion / solubility and dispersion / dissolution after dissolution in an aqueous medium, and further dispersed / dissolved in an aqueous medium.
- a food or pharmaceutical product it is highly preferred for its appearance, taste, flavor, and texture such as graininess.
- composition according to the present invention is used after being dispersed / dissolved in aqueous medium water, characterized by comprising lactic acid bacteria containing a high concentration of mineral components.
- the lactic acid bacterium used in the present invention contains a mineral component at a high concentration.
- minerals contained in the lactic acid bacterium used in the present invention include magnesium, iron, manganese, zinc, copper, selenium, chromium, and a mineral power that also has a group power that also has molybdenum power. Ral. These minerals may be contained in lactic acid bacteria not only alone but also in plural. According to a preferred embodiment of the present invention, the types and preferred contents of minerals are as follows. That is,
- Magnesium is preferably 7% by weight or more, more preferably 14% by weight, ferrous iron is preferably 4.5% by weight or more, more preferably 9.5% by weight or more, and manganese is 5% by weight or more. Is more preferably 10% by weight or more, zinc is preferably 4.5% by weight or more, more preferably 9.5% by weight or more, and copper is 0.9% by weight or more. More preferably, it is 1.8% by weight or more, selenium is preferably 0.05% by weight or more, more preferably 0.1% by weight or more, and chromium is more preferably 0.1% by weight or more. Is 0.2% by weight or more, and molybdenum is preferably 0.1% by weight or more, more preferably 0.2% by weight or more.
- the lactic acid bacteria used in the present invention can basically be obtained by culturing in a medium containing the mineral to be contained. Strength that enables more efficient uptake by optimizing the medium composition other than the mineral component In the present invention, the mineral component is contained at a high concentration and there is no problem with safety to humans. As far as it is concerned, its production method is not particularly limited.
- Lactic acid bacteria that can be used in the present invention can be obtained, for example, by the method described in the above-mentioned W092Z21749 (corresponding JP-A-6-508516).
- Biogurt includes Biogurt Magnesium (containing 14-16% magnesium), Biogurt Iron (containing 9.5-11% iron), Biogurt Manganese (containing 10-12% manganese), Biogurt Zinc (9. 5-10% contained), Biogurt Copper (containing 1.8-1.3% copper), etc., and V and deviation can also be suitably used in the present invention.
- the composition according to the present invention is used after being dispersed and dissolved in an aqueous solvent.
- the composition according to the present invention is taken by animals including humans after being dispersed / dissolved in this aqueous solvent.
- the composition according to the present invention has excellent dispersion 'solubility and dispersion' stability after dissolution in an aqueous medium. It is. In particular, since it is easily dispersed and dissolved in an aqueous medium, it is preferably used as a composition prepared at the time of use and ingested. In the case of foods and medicines, from the viewpoint of stability, it may be advantageous to be provided in the form of a composition and to be used as dispersed and dissolved in an aqueous medium at the time of use.
- the composition according to the present invention a person usually stirs in a container such as a cup,
- It can be completely dispersed and dissolved in a time of 40 seconds or less, and in a more preferable embodiment, it can be completely dispersed and dissolved in a time of 20 seconds or less, and further about 10 seconds.
- the composition according to the present invention is used after being dispersed and dissolved in an aqueous solvent immediately before ingestion.
- “ingested” broadly includes taking the composition according to the present invention dispersed and dissolved in an aqueous solvent into the body through the digestive tract, and is thus eaten orally. In addition to this, it includes feeding and ingesting enterally by tube. Therefore, the composition according to the present invention is specifically provided as a food or a medicine, and according to a preferred embodiment of the present invention, the food or medicine for mineral supplementation, and further the nutritional supplement enriched with mineral components Served as food, low calorie food, or diet food.
- the composition according to the present invention since the composition according to the present invention dispersed and dissolved in an aqueous medium can be used as a liquid food, the composition according to the present invention is provided as a food for liquid food preparation. Is done.
- the aqueous medium in which the composition according to the present invention is dispersed / dissolved is not particularly limited as long as it has water as a main component and can provide effects such as excellent dispersibility / solubility according to the present invention described later.
- Specific examples thereof include water containing hot water, milk, soy milk, whey drink, soft drink, etc., preferably water containing hot water.
- the composition according to the present invention is excellent in dispersion / solubility and stability after dispersion / dissolution in an aqueous medium. Further, those that are dispersed and dissolved in an aqueous medium have an advantage that they are good as food or pharmaceuticals in appearance, taste, flavor, and texture such as roughness.
- the weight limit of yeast containing a high mineral content suggested by JP-A-2001-46016 is 0.2 weight. Beyond% Also exhibits good dissolution 'dispersibility and stability. Therefore, the mineral component can be added to the composition at a higher concentration than in the case of yeast, and the intake amount can be increased.
- composition according to the present invention is advantageous in terms of its appearance, taste, flavor, and texture such as roughness, as compared to yeast with a high mineral content.
- lactic acid bacteria containing a high concentration of mineral components are advantageous from the above viewpoint as compared to yeast containing a high concentration of mineral components.
- the composition according to the present invention When the composition according to the present invention is dissolved and dispersed at the time of use in an aqueous medium, the form thereof is powdery, granular, concentrated liquid containing a high concentration of lactic acid bacteria, semisolid, etc.
- the composition according to the present invention is optionally granulated with other components as described below to form a powder.
- the granulation method is not particularly limited, but it is preferable to use spray drying, stirring granulation method, fluidized bed granulation method, rolling granulation method, extrusion granulation method and the like. Further, after granulation, other components described later may be mixed to obtain a composition according to the present invention.
- the yarn composition according to the present invention may be produced so that its bulk specific gravity is in the range of 0.22 to 0.45 g / cm 3 . It also has excellent stability afterwards, and also likes the viewpoint of food texture such as appearance, taste, flavor, and roughness as food or medicine.
- the content of the lactic acid bacterium in the composition according to the present invention may be appropriately determined in consideration of the concentration of the mineral component to be contained, but is contained 0.001% by weight or more in terms of lactic acid bacterium in a dry form. Is more preferably 0.01 to 10% by weight. Furthermore, according to a preferred embodiment of the present invention, the content of lactic acid bacteria is in terms of lactic acid bacteria in a dry form,
- lactic acid bacterium contains magnesium, 0.4 to 8% by weight is preferred. If the lactic acid bacterium contains iron, 0.02-0.5% by weight is preferred.If the lactic acid bacterium contains manganese, 0. 007-0. 2% by weight is preferred When lactic acid bacteria contain zinc, 0.01-0. 3% by weight is preferred When lactic acid bacteria contain copper, 0. 007-0. 2% by weight Preferred If lactic acid bacteria contain selenium, 0.005-0. 1% by weight is preferred. If lactic acid bacteria contain chromium, 0.003-0.06% by weight is preferred. Lactic acid bacteria contain molybdenum. In the case of waste, 0.002-0.04% by weight is preferable.
- the composition according to the present invention can contain other components required as a medicine or food in addition to the lactic acid bacteria described above.
- it can contain proteins, lipids, carbohydrates, dietary fiber, vitamins and the like.
- Proteins include milk proteins (whole milk proteins, strength sodium zein, casein calcium, etc.) and their hydrolysates, other animal proteins (egg protein, gelatin, etc.) and their hydrolysates, and vegetable proteins. (Such as soybean) and hydrolysates thereof.
- the composition according to the present invention may be a composition containing protein as a main component.
- the total protein content may be determined as appropriate. For example, if one-third of the daily intake requirement is taken as a guide for intake, about 13 to 30 g / 400 ml is preferable.
- composition according to the present invention may further comprise dry yeast (for example, beer fermenter, baker's yeast, etc.).
- dry yeast for example, beer fermenter, baker's yeast, etc.
- the mineral component is provided by being contained in lactic acid bacteria, and as a supplement or supplement to it, sodium, calcium, magnesium, potassium, and iron are acceptable as foods in the form of a salt. It is also possible to include.
- the total calorific value of the composition according to the present invention may be appropriately determined.
- a composition intended for nutritional supplement during dieting about 0.4 kcal / ml.
- the total calorific value is preferably 300 kcal or less.
- the total heat per dose is 150, 160, 170, 180, 190, 20 0, 210, 220, 230, 240, 250, 260, 270, 280 290, 300, 310, 320, 330, 340, or 3 50kcal.
- composition according to the present invention can also comprise yeast containing a high level of mineral components in a range that does not affect palatability, dispersibility, and stability.
- a liquid, semi-solid, or jelly comprising at least dispersing and dissolving the composition according to the present invention in an aqueous medium.
- a method of making a one-piece composition is provided.
- the composition according to the present invention is excellent in dispersion “solubility” and stability after dissolution in an aqueous medium. Therefore, according to this invention According to the production method, it is possible to produce a liquid, semi-solid or jelly composition that is efficient and excellent in stability.
- the liquid, semi-solid, or jelly-like composition obtained by the production method according to the present invention is specifically a food or medicine, preferably a food or medicine for mineral supplementation, Is used as a nutritional supplement, low-calorie food, diet food, and liquid food with enhanced minerals.
- Lactic acid bacteria and yeasts used in the following examples and comparative examples, and their mineral content are as follows.
- the above lactic acid bacteria or yeast and the components shown in Table 2 below were prepared.
- the components listed in the table were mixed, and granulated for 30 minutes in a fluidized bed granulator manufactured by Freund Sangyo Co., Ltd. using 230 ml of water as a binder with respect to 1 kg of the mixture.
- the inlet temperature of the fluidized bed granulator at this time was 75 degrees Celsius and the exhaust temperature was 40 degrees Celsius.
- Example 1 The granulated composition was sieved with 20 mesh, and the specific gravity was adjusted to 0.30 ⁇ 0.05 gZcm 3 and moisture value 3 ⁇ 1%.
- the resulting compositions were referred to as Example 1 and Comparative Example 1.
- the mineral and vitamin components are mixed in the same amounts as shown in Table 3.
- the amount of lactic acid bacteria or yeast was adjusted with brewer's yeast so that the amount of cells was equal.
- Vitamin A 240 g 240 / g Vitamin 1.25 mg 1.25 mg Vitamin B 2 1.48 mg 1.48 mg Vitamin B 6 1.46 mg 1.46 mg Vitamin C 40 mg 40 mg Vitamin! ) 2.0 / g 2.0 / g Vitamin E 4.0 mg 4.0 mg Vitamin K 2 25 // g Niacin 16.7 mg 16.7 mg Pantothenic acid 5.2 mg 5.2 mg Folic acid 104.5 / g Calcium 210 mg 210 mg Magnesium lOOmg lOOmg Iron 3.8 mg 3.8 mg Manganese 1.25 mg 1.25 mg Zinc 2.5 mg 2.5 mg 2.5 mg Chromium 10 g 10 g Selenium 9.0 / zg 9.0 / g
- compositions having the same components as those of Example 1 and Comparative Example 1 except that the specific gravity was changed by changing the granulation conditions and the like were prepared, and these were prepared as Examples 2 to 5 and Comparative Examples. 2 ⁇ 5
- the dispersions obtained in Experimental Example 1 and Comparative Example 2 were subjected to sensory evaluation by 12 skilled panelists. That is, the appearance, taste / flavor, and texture (roughness) of the prepared dispersion were evaluated.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005023874 | 2005-01-31 | ||
JP2005-023874 | 2005-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006080522A1 true WO2006080522A1 (ja) | 2006-08-03 |
Family
ID=36740538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/301539 WO2006080522A1 (ja) | 2005-01-31 | 2006-01-31 | ミネラル含有乳酸菌を含んでなる食品または医薬品 |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR20080009680A (ja) |
CN (1) | CN101163414A (ja) |
WO (1) | WO2006080522A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020036229A1 (ja) * | 2018-08-17 | 2020-02-20 | イチビキ株式会社 | 乳酸菌、血中鉄増加剤、及び貧血改善剤 |
US12121550B2 (en) | 2018-08-17 | 2024-10-22 | Ichibiki Co., Ltd. | Lactic acid bacterium, blood iron increasing agent, and anemia improving agent |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240104324A (ko) | 2022-12-27 | 2024-07-05 | 농업회사법인주식회사글로벌코퍼레이션 | 쌀발효당을 베이스로 염증성 장 질환 예방과 글루텐 분해능을 가진 유산균을 활용하여 제조된 유산균 젤리 및 그 제조 방법 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54157890A (en) * | 1978-05-29 | 1979-12-13 | Sapporo Breweries | Production of microorganism cells |
JPS62220157A (ja) * | 1986-03-20 | 1987-09-28 | Masato Akutsu | ゲルマニウム含有食品の製造法 |
JPH03505520A (ja) * | 1988-03-09 | 1991-12-05 | プロビ エービー | 栄養剤組成物及びその製造方法 |
JPH06508516A (ja) * | 1991-06-03 | 1994-09-29 | イノヴィ・ナムローゼ・フェンノートシャップ | 微量元素補強添加剤、その調製方法、添加剤含有配合物およびその使用 |
JP2000247895A (ja) * | 1999-02-25 | 2000-09-12 | Meiji Milk Prod Co Ltd | 自己免疫疾患予防組成物 |
JP2001000143A (ja) * | 1999-06-24 | 2001-01-09 | Meiji Milk Prod Co Ltd | Helicobacterpylori除菌性飲食品 |
JP2004018469A (ja) * | 2002-06-18 | 2004-01-22 | National Agriculture & Bio-Oriented Research Organization | 抗アレルギー剤 |
-
2006
- 2006-01-31 KR KR1020077019820A patent/KR20080009680A/ko not_active Application Discontinuation
- 2006-01-31 WO PCT/JP2006/301539 patent/WO2006080522A1/ja not_active Application Discontinuation
- 2006-01-31 CN CNA200680003122XA patent/CN101163414A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54157890A (en) * | 1978-05-29 | 1979-12-13 | Sapporo Breweries | Production of microorganism cells |
JPS62220157A (ja) * | 1986-03-20 | 1987-09-28 | Masato Akutsu | ゲルマニウム含有食品の製造法 |
JPH03505520A (ja) * | 1988-03-09 | 1991-12-05 | プロビ エービー | 栄養剤組成物及びその製造方法 |
JPH06508516A (ja) * | 1991-06-03 | 1994-09-29 | イノヴィ・ナムローゼ・フェンノートシャップ | 微量元素補強添加剤、その調製方法、添加剤含有配合物およびその使用 |
JP2000247895A (ja) * | 1999-02-25 | 2000-09-12 | Meiji Milk Prod Co Ltd | 自己免疫疾患予防組成物 |
JP2001000143A (ja) * | 1999-06-24 | 2001-01-09 | Meiji Milk Prod Co Ltd | Helicobacterpylori除菌性飲食品 |
JP2004018469A (ja) * | 2002-06-18 | 2004-01-22 | National Agriculture & Bio-Oriented Research Organization | 抗アレルギー剤 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020036229A1 (ja) * | 2018-08-17 | 2020-02-20 | イチビキ株式会社 | 乳酸菌、血中鉄増加剤、及び貧血改善剤 |
JP6675521B1 (ja) * | 2018-08-17 | 2020-04-01 | イチビキ株式会社 | 乳酸菌、血中鉄増加剤、及び貧血改善剤 |
US12121550B2 (en) | 2018-08-17 | 2024-10-22 | Ichibiki Co., Ltd. | Lactic acid bacterium, blood iron increasing agent, and anemia improving agent |
Also Published As
Publication number | Publication date |
---|---|
CN101163414A (zh) | 2008-04-16 |
KR20080009680A (ko) | 2008-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6041459B2 (ja) | 乳鉱物およびカゼイン分画を用いる体重状態の治療のための組成物および方法 | |
KR101067266B1 (ko) | 영양 조성물 | |
JP4702745B2 (ja) | ミネラル吸収促進剤及びその用途 | |
TW200812503A (en) | Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass | |
JP2003500445A (ja) | 栄養補助物 | |
JP6728071B2 (ja) | 筋肉合成促進剤 | |
JPH02289520A (ja) | ビフィズス菌増殖促進剤 | |
JP2008247748A (ja) | 透析患者用栄養組成物 | |
JP3649945B2 (ja) | 栄養粥 | |
JP2009286703A (ja) | D−タガトースを有効成分とする体脂肪蓄積改善剤およびメタボリックシンドローム改善剤 | |
JP2005097161A (ja) | 抗疲労用組成物およびこれを含有する食品 | |
JP5414142B2 (ja) | 脂質代謝改善剤 | |
CN105581331B (zh) | 一种补钙营养组合物 | |
WO2006080522A1 (ja) | ミネラル含有乳酸菌を含んでなる食品または医薬品 | |
JPH07222571A (ja) | 運動選手用飲食品 | |
KR20060024766A (ko) | 혈중 저분자량질소함유화합물의 농도를 저감시키는질병개선용식품 | |
JP2006230404A (ja) | ミネラル含有乳酸菌を含んでなる食品または医薬品 | |
WO2006038613A1 (ja) | ダイフラクトース アンハイドライド含有経口組成物 | |
JP2002142720A (ja) | 栄養組成物 | |
JP3285959B2 (ja) | 長期療養患者用液状調製栄養食品 | |
JPH0998738A (ja) | 易吸収性カルシウム組成物 | |
JP2020132621A (ja) | 皮膚ガス放散調節用組成物 | |
JP7295269B2 (ja) | 経腸摂取用組成物 | |
JP4902349B2 (ja) | 筋ジストロフィー進行抑制組成物 | |
JP5377203B2 (ja) | 術後補助食 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 200680003122.X Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077019820 Country of ref document: KR |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06712682 Country of ref document: EP Kind code of ref document: A1 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 6712682 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |